Pentafluorosulfanyl-substituted biaryl derivatives as MATE-type transporter inhibitors targeting drug-resistant bacteria

  • Bioorg Med Chem. 2024 Feb 1:99:117606. doi: 10.1016/j.bmc.2024.117606.
Susumu Shinya  1 Kentaro Kawai  2 Naoki Kobayashi  3 Yukiko Karuo  1 Atsushi Tarui  1 Kazuyuki Sato  1 Masato Otsuka  1 Masaaki Omote  1
Affiliations
  • 1. Faculty of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge-cho, Hirakata, Osaka 573-0101, Japan.
  • 2. Faculty of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge-cho, Hirakata, Osaka 573-0101, Japan. Electronic address: [email protected].
  • 3. Faculty of Agriculture, Setsunan University, 45-1 Nagaotoge-cho, Hirakata, Osaka 573-0101, Japan.
Abstract

Multidrug and toxin extrusion (MATE) inhibitors improve the antimicrobial susceptibility of drug-resistant bacteria by preventing the efflux of administered Antibiotics. In this study, we optimized the chemical structure of a previously identified bacterial-selective MATE inhibitor 1 (EC50 > 30 µM) to improve its activity further. Compound 1 was divided into three fragments (aromatic part, linker part, and guanidine part), and each part was individually optimized. Compound 31 (EC50 = 1.8 µM), a novel pentafluorosulfanyl-containing molecule synthesized following optimized parts, showed antimicrobial activity against MATE-expressing strains at concentrations lower than conventional inhibitor 1 when co-administrated with norfloxacin. Furthermore, 31 was not cytotoxic at effective concentrations. This suggests that compound 31 can be a promising candidate for combating Bacterial infections, particularly those resistant to conventional Antibiotics by MATE expression.

Keywords
Antimicrobials; Efflux pump inhibitor; Multidrug and toxic compound extrusion; Multidrug-resistant bacteria; Pentafluorosulfanyl.
Products